Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,425.00
Bid: 2,390.00
Ask: 2,405.00
Change: 0.00 (0.00%)
Spread: 15.00 (0.628%)
Open: 2,435.00
High: 2,435.00
Low: 2,390.00
Prev. Close: 2,425.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Mar 2024 15:49

RNS Number : 5215F
Morgan Sindall Group PLC
04 March 2024
 

Morgan Sindall Group plc (the "Company")

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

1.

Details of Restricted Person/person closely associated with them ("PCA")

a)

Name

John Morgan (Chief Executive)

Steve Crummett (Finance Director)

2.

Reason for the notification  

a)

Position/status

Members of the Board of directors

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  

a)

Name

Morgan Sindall Group plc

b)

LEI

2138008339ULDGZRB345

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 5 pence each

 

ISIN: GB0008085614 

b)

Nature of the transaction

Grant of conditional awards over Ordinary Shares on 4 March 2024, under the Company's 2023 Long Term Incentive Plan, adopted by the Company on 1 August 2023 ("2023 LTIP"). Each conditional award will vest on 4 March 2027 subject to the satisfaction of performance criteria. Each conditional award carries a right to receive, on vesting, an amount linked to dividends paid on the Ordinary Shares subject to the conditional award. The dividend equivalent can be settled in cash or Ordinary shares of the Company. The vesting of the award will also be subject to a two-year holding period whereby any vested shares (net of any tax liability) will be retained in the Company's appointed nominee in accordance with the Company's directors' remuneration policy.

c)

Price(s) and volume(s)

Name

Price(s)

Volume(s)

John Morgan

N/A

53,105

Steve Crummett

N/A

31,766

d)

Aggregated information

- Aggregated volume

- Price

As above

 

e)

Date of the transaction

 4 March 2024

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSEVRISIIS
Date   Source Headline
8th Apr 20218:00 amRNSDirectorate Change
1st Apr 202111:59 amRNSTotal Voting Rights
25th Mar 202112:51 pmRNSAnnual Financial Report
12th Mar 20214:37 pmRNSHolding(s) in Company
11th Mar 20214:55 pmRNSDirector/PDMR Shareholding
10th Mar 20213:01 pmRNSDirector/PDMR Shareholding
8th Mar 20214:54 pmRNSDirector/PDMR Shareholding
8th Mar 20214:28 pmRNSDirector/PDMR Shareholding
5th Mar 20213:06 pmRNSDirector/PDMR Shareholding
1st Mar 202111:25 amRNSTotal Voting Rights
25th Feb 20217:00 amRNSFinal Results
17th Feb 20219:06 amRNSHolding(s) in Company
8th Feb 20217:00 amRNSNotice of Results
3rd Feb 20213:42 pmRNSHolding(s) in Company
1st Feb 202110:40 amRNSTotal Voting Rights
22nd Jan 20214:58 pmRNSHolding(s) in Company
4th Jan 202110:56 amRNSTotal Voting Rights
8th Dec 20202:00 pmRNSAdditional Listing
7th Dec 20209:23 amRNSDirector Declaration
3rd Dec 20203:20 pmRNSDirector/PDMR Shareholding
1st Dec 202012:55 pmRNSTotal Voting Rights
4th Nov 20203:00 pmRNSDividend Declaration
4th Nov 20207:00 amRNSTrading Update
2nd Nov 202012:24 pmRNSTotal Voting Rights
20th Oct 20209:57 amRNSBlock listing Interim Review
1st Oct 20201:28 pmRNSTotal Voting Rights
23rd Sep 20205:00 pmRNSHolding(s) in Company
18th Sep 202012:02 pmRNSPrice Monitoring Extension
15th Sep 202010:00 amRNSAdditional Listing
9th Sep 20202:49 pmRNSHolding(s) in Company
2nd Sep 202012:07 pmRNSSecond Price Monitoring Extn
2nd Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20209:11 amRNSTotal Voting Rights
25th Aug 20204:06 pmRNSHolding(s) in Company
21st Aug 20204:15 pmRNSHolding(s) in Company
6th Aug 202012:25 pmRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20209:54 amRNSTotal Voting Rights
27th Jul 20207:00 amRNSForward funding secured for £185m New Victoria
14th Jul 20208:30 amRNS£252m forward funding deal of Lewisham Gateway
7th Jul 20203:21 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSNotice of Results
1st Jul 20202:49 pmRNSHolding(s) in Company
1st Jul 20208:50 amRNSTotal Voting Rights
25th Jun 20203:29 pmRNSHolding(s) in Company
22nd Jun 202011:27 amRNSDirector Declaration
18th Jun 20202:02 pmRNSHolding(s) in Company
10th Jun 202012:02 pmRNSPrice Monitoring Extension
1st Jun 202011:48 amRNSTotal Voting Rights
28th May 20202:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.